Thermo Fisher Scientific has grown revenue 2.1% a year over three years and 3.9% a year over five, with earnings per share compounding at 8.3%. Revenue growth, 3-year annual rate: +2.1% (Diagnostics & Research median +9.1%). Revenue growth, 5-year rate: +3.9%, growth has slowed since the five-year average. Earnings per share, 3-year rate: +8.3%, earnings outgrew revenue: margins or the share count worked for shareholders. Years of annual history on file: 19, FY2007 to FY2025, as filed.

TMOThermo Fisher Scientific

HealthcareUSD

$633.95

$437.9052 weeks$638.18

Is it growing?

Is TMO growing?

Thermo Fisher Scientific has grown revenue 2.1% a year over three years and 3.9% a year over five, with earnings per share compounding at 8.3%.

+2.1%

Revenue growth, 3-year annual rate · Diagnostics & Research median +9.1% · growing slowly · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +3.9%
Revenue growth, 5-year rate · +2.1% over three · growth has slowed since the five-year average
Earnings per share, 3-year rate: +8.3%
Earnings per share, 3-year rate · revenue +2.1% · earnings outgrew revenue: margins or the share count worked for shareholders
Years of annual history on file: 19
Years of annual history on file · FY2007 to FY2025, as filed